Tolga Onur BADAK

Dr. Tolga Onur BADAK

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

10 May 2024 in Medicine
Verified
Journal Article
Open access
HUHasan Uncu
Hasan Uncu
TBTolga Onur BADAK
Tolga Onur BADAK
HUHaci Ali Ucak
Haci Ali Ucak
FCFerid Cereb
Ferid Cereb
ACAhmet Cakallioglu
Ahmet Cakallioglu
Warfarin, a widely utilized anticoagulant, is paramount for preventing thromboembolic events in patients with mechanical heart valve replacements. However, its narrow therapeutic index can lead to over-anticoagulation and overdose, resulting in serious health risks. This study examines the efficacy of human prothrombin complex concentrate (PCC) in managing warfarin overdose, in comparison with traditional treatments. A retrospective analysis was conducted on 162 adults who presented with warfarin overdose (INR > 5.0) at a tertiary care hospital between 2016 and 2020. Participants were divided into 2 groups—those treated with PCC (n = 57) and those treated with conventional methods (n = 105), including vitamin K and fresh frozen plasma. The primary outcome was the rate of reaching the target (International Normalized Ratio) INR within 24 hours. Secondary outcomes included transfusion requirements, thromboembolic events, adverse reactions, 30-day mortality, and length of hospital stay. PCC demonstrated significant efficacy, with 89.5% of patients achieving the target INR within 24 hours, compared to 64.8% in the control group ( P < .05). The PCC group also had reduced transfusion requirements and a shorter average hospital stay. There was no significant difference in thromboembolic events or adverse reactions between the 2 groups, and the reduced 30-day mortality in the PCC group was not statistically significant. Human prothrombin complex concentrate is associated with rapid reaching the target INR, decreased transfusion needs, and shortened hospitalization, making it a promising option for warfarin overdose management. While the results are encouraging, larger, multicenter, randomized controlled trials are necessary to further validate these findings and optimize PCC administration protocols.

21 March 2026 in The Journal of Vascular Access
Verified
Journal Article
Open access
SASibel Ada
Sibel Ada
BABerrak Itır Aylı
Berrak Itır Aylı
TBTolga Onur BADAK
Tolga Onur BADAK
Background: Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis, yet primary failure and early dysfunction remain common, thereby prolonging catheter dependence and increasing costs. Traditional prediction models show limited discrimination, and few studies have combined machine-learning (ML) methods with formal assessment of clinical utility. This study aimed to identify predictors of AVF failure and compare ML models with logistic regression in a Turkish hemodialysis cohort, and to derive a clinical risk score. Methods: In this retrospective study, 385 adults with native AVFs (171 failures, 214 patent) operated between January 2018 and November 2024 were analyzed. Demographic, clinical, and laboratory variables were extracted from electronic records. Standard logistic regression (GLM), penalized logistic regression (LASSO), Random Forest, and XGBoost models were fitted and evaluated using 10-fold cross-validation and an independent test set (75%/25% split). LASSO coefficients were translated into a hand-calculable clinical risk score. Results: Patients with AVF failure were older and had lower BMI, albumin, and creatinine than those with patent accesses. In multivariable logistic regression, higher urea and lower BMI and albumin independently predicted failure. On the test set, AUCs were 0.731 (GLM), 0.876 (LASSO), 0.918 (Random Forest), and 0.884 (XGBoost). Cross-validated mean AUCs ranged from 0.906 (GLM) to 0.950 (XGBoost), with Brier scores 0.079–0.116 and generally good calibration. A 30% risk threshold suggested a clinically reasonable balance between sensitivity and specificity, and decision-curve analysis showed net benefit for all ML models versus treat-all/none. The clinical risk score stratified patients into low (⩽3 points), intermediate (4–7), and high (⩾8) risk. Conclusion: ML models, particularly ensemble methods, showed improved discrimination compared with standard logistic regression for predicting AVF failure and supported a simple, clinically usable risk score for stratified surveillance.

22 December 2025 in Cukurova Medical Journal
Verified
Journal Article
Open access
TBTolga Onur BADAK
Tolga Onur BADAK
FCFerid Cereb
Ferid Cereb
Purpose: This study aimed to quantitatively compare the efficacy of venous drainage and the requirements for vacuum-assisted venous drainage (VAVD) between bicaval and multistage femoral venous cannulation strategies in minimally invasive direct coronary artery bypass (MIDCAB). Materials and Methods: In this retrospective, single-center study, 60 patients who underwent MIDCAB between 2018 and 2024 were analyzed. Thirty patients received bicaval cannulation via the right internal jugular and femoral veins (Group 1), while 30 patients underwent single cannulation using a multistage femoral venous cannula (Group 2). Primary outcomes included venous reservoir volume at the initiation of cardiopulmonary bypass (CPB) and the need for VAVD. Secondary outcomes comprised CPB duration and major postoperative complications. Results: Mean pump flow rate was comparable between groups (Group 1: 4.5 ± 0.4 L/min vs. Group 2: 4.3 ± 0.5 L/min). However, mean initial venous reservoir volume was greater in Group 1 (824 ± 124 mL vs. 641 ± 95 mL). The requirement for VAVD was more frequent in Group 2 (82.7% vs. 24.1%). Additionally, CPB duration was longer in Group 2 (191.9 ± 24.4 min vs. 149.6 ± 39.6 min). No major postoperative complications were observed in either group. Conclusion: Multistage femoral venous cannulation was associated with inferior venous drainage, necessitating more frequent vacuum support and resulting in prolonged CPB times. Bicaval cannulation may therefore provide a more reliable approach to achieving optimal surgical conditions in MIDCAB.

17 January 2022
Verified
Book
Open access
PDF file
BİBaşak Oğuz İnan
Başak Oğuz İnan
MKMuhammet Kızmaz
Muhammet Kızmaz
GAGülru Avcı
Gülru Avcı
TGTuğba Sevinç Gamsız
Tuğba Sevinç Gamsız
YIYildiz Ipek
Yildiz Ipek
AYArda Şakir Yılmaz
Arda Şakir Yılmaz
Anamnez Alma Şema ve Özellikler Başak OĞUZ İNAN Hasta Şikayeti ve Kimlik Bilgisi Muhammet KIZMAZ Anamnez Alma Gülru AVCI Özgeçmiş Tuğba Sevinç GAMSIZ Soy Geçmiş Yıldız İPEK Sosyal Durum ve Alışkanlıklar Vildan GÜRSOY Kullandığı İlaçlar Hilal HEYBELİ Beden Fonksiyonları Fatma AYKAŞ Genel Durum Sorgusu Alper Tuna GÜVEN Solunum Sistemiyle İlgili Sorgu Sonat Pınar KARA Kardiyovasküler Sistemle İlgili Sorgu Tolga Onur BADAK Gastrointestinal Sistemle İlgili Sorgu Gülden BİLİCAN Üroloji’de Anamnez Ersin GÖKMEN Lokomotor Sistemle İlgili Sorgulama Hatice AĞIR Sinir Sistemi İle İlgili Sorgu Ayşegül AKKAN SUZAN Fizik Muayene Usulleri–İnspeksiyon İsmail KIRLI Fizik Muayene Usulleri (Palpasyon) Ayşe Nilgün KUL Perküsyon Deniz TAZEOĞLU Oskültasyon Mehmet Emre AY Metabolik Nedenlere Bağlı Karın Ağrıları Özgür BAHADIR Beslenme Durumunun Değerlendirilmesi Büşra Betül ÇAĞIR Boy ve Önemli Gelişim Hastalıkları (I) Seçil ÖZIŞIK Boy ve Önemli Gelişim Hastalıkları (II) Mustafa CAN Postür Muayenesi Hatice AĞIR Anormal Hareket Bozuklukları-I Fatma Ebru ALGÜL Anormal Hareket Bozuklukları-II Fatma Ebru ALGÜL Yürüyüş Funda GÖKGÖZ DURMAZ Konuşmanın Değerlendirilmesi ve Konuşma Bozuklukları Tuba GÜLLÜ KOCA Koku Alma Ali YEŞİLTEPE Ateş Aslıhan METE YILDIRIM Ateş ve Tipleri Pınar ERGEN, Fatma YILMAZ KARADAĞ Terleme Nursel AKBAY Tırnaklar (I) Müge BİLGE Tırnaklar (II) Fatma KAPLAN EFE Epidermis, Dermis, Subkutan Doku Sümeyra Alan YALIM Primer Deri Lezyonları Nida ÖZTOP Sekonder Deri Lezyonları Şengül BEYAZ Derinin Muayenesi Gökçem YALIN KOCAMAZ Baş Muayenesi Aylia YEŞİLOVA Yüzün ve Saçın Muayenesi-Özel Hastalıklarda Müçteba CAN Göz Hastalıklarında Ön Segment Muayenesi Ayşe Yeşim ORAL, İbrahim Ethem AY Göz Hastalıklarında Arka Segment Muayenesi Müberra AKDOĞAN, İbrahim Ethem AY Burun Muayenesi Tuğba Sevinç GAMSIZ Dudakların Muayenesi Gülşah BOZ Kulaklar Zekiye Pınar İPEK EYVAZ Boyun Muayenesi, Boyun Damarlarının Muayenesi, Boyun Lenf Ganglionlarının Muayenesi, Trachea Muayenesi Selman GENCER Tiroid Muayenesi Ebru ÖZDEN YILMAZ, Arda Şakir YILMAZ

30 June 2024 in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
Verified
Journal Article
Open access
PDF file
TBTolga Onur BADAK
Tolga Onur BADAK
FCFerid Cereb
Ferid Cereb
HUHacı Ali Uçak
Hacı Ali Uçak
HUHasan Uncu
Hasan Uncu
OOOzge Ozalp
Ozge Ozalp
OBOzlem Boz
Ozlem Boz
Aim: Warfarin, a widely prescribed anticoagulant, exhibits considerable variability in patient response, making its clinical use challenging due to a narrow therapeutic window. This study aimed to evaluate the prevalence of CYP2C9 and VKORC1 gene polymorphisms in a cohort of 87 Turkish patients who underwent cardiac valve surgery and received warfarin therapy, as well as to assess their impact on warfarin dosage requirements. Methods: The frequencies of CYP2C9 and VKORC1 polymorphisms were analyzed, and patients were stratified based on the presence or absence of mutations affecting warfarin dosing. Results: Revealed that patients carrying at least one CYP2C9 or VKORC1 polymorphism required a significantly lower weekly warfarin dose to achieve the optimal international normalized ratio (INR). Conclusion: This study highlights the critical role of genetic factors in determining warfarin dosage and supports the integration of pharmacogenetic testing into clinical practice to personalize warfarin therapy. Such an approach has the potential to enhance treatment outcomes and minimize the risk of adverse events. Further research involving larger sample sizes and diverse patient populations is warranted to validate these findings and refine the current understanding of the genetic determinants of warfarin dosing.